Quick Answer
GLP-1 shortages are improving as of April 2026, but some doses of Ozempic, Wegovy, Mounjaro, and Zepbound still face periodic gaps. Novo Nordisk and Eli Lilly have expanded manufacturing. If your medication is unavailable, call multiple pharmacies, ask your doctor about alternatives, check back regularly, and consider temporary dose adjustments.
Key Points
- GLP-1 shortages are easing but some doses still affected (varies by medication, dose, and location)
- Wegovy 2.4 mg is now more widely available after months of shortage
- Ozempic 1 mg and 2 mg doses still see periodic shortages
- Mounjaro and Zepbound availability improving as Lilly expands production
- Call multiple pharmacies — stock varies significantly between locations
- Ask your doctor about alternative medications or dose adjustments
- Check regularly — new shipments arrive weekly
Helpful products:
- Weekly pill organizer — track medication supply (7-day planner, easy-open lids)
- Digital bathroom scale — monitor weight during medication interruptions (#1 best seller, 400 lb capacity)
- Don't stop medication suddenly without consulting your doctor
- Supply is improving as manufacturers expand production capacity
Statistics
- FDA drug shortages: Some GLP-1 doses remain on FDA shortage list as of April 2026; others have been resolved (FDA, 2026)
- Production capacity: Novo Nordisk opened a new manufacturing facility in North Carolina; Eli Lilly expanded production at multiple sites (Industry reports, 2026)
- Demand growth: GLP-1 prescriptions increased 400%+ since 2020 (CDC, 2025)
- Wegovy 2.4 mg: Now more widely available after extended shortage period (FDA shortage database, April 2026)
- Ozempic 1 mg/2 mg: Still intermittently short in many regions (FDA shortage database, April 2026)
Medical Review
This article was reviewed by the GLP Spot Medical Review Board. Our medical review process ensures all information is current with FDA shortage notifications and clinical best practices for managing medication interruptions.
GLP-1 Shortages: What to Do If You Can't Find Your Meds
GLP-1 shortages have made it hard for many people to fill their prescriptions. Here's what to do if your pharmacy is out.
Why Shortages Happen
- Demand is higher than supply
- Manufacturing can't keep up
- Raw materials are limited
- More people are getting prescriptions
Which Meds Are Affected
As of April 2026, here is where things stand:
Ozempic (semaglutide)
- 0.25 mg and 0.5 mg starter doses — generally available
- 1 mg dose — periodic shortages in many regions
- 2 mg dose — intermittent availability
Wegovy (semaglutide)
- 0.25 mg, 0.5 mg, and 1 mg doses — generally available
- 1.7 mg dose — improving availability
- 2.4 mg dose — now more widely available after extended shortage
Mounjaro (tirzepatide)
- 2.5 mg and 5 mg doses — generally available
- 7.5 mg and 10 mg doses — improving
- 12.5 mg and 15 mg doses — some regions still see gaps
Zepbound (tirzepatide)
- 2.5 mg and 5 mg doses — generally available
- 7.5 mg and 10 mg doses — improving
- 12.5 mg and 15 mg doses — availability varies
Availability changes weekly. Always check with your pharmacy.
What to Do If You Can't Find Your Med
1. Call Multiple Pharmacies
Different pharmacies have different stock. Don't give up after one "no."
2. Ask About Alternatives
Talk to your doctor about switching to a different GLP-1 that might be available.
3. Check Regularly
Supply changes often. New shipments come in. It's worth checking weekly.
4. Work with Your Doctor
Your doctor may know about availability and can help adjust your dose or switch medications.
If You Have Supply
- Don't skip doses to stretch it out
- Order refills early
If You Can't Get Supply
- Don't stop suddenly without talking to your doctor
- Ask about alternatives
- Focus on diet and exercise in the meantime
Looking Ahead
Supply is improving. Novo Nordisk opened a new production facility in North Carolina in early 2026. Eli Lilly has expanded tirzepatide production at multiple sites. Most GLP-1 doses are expected to be consistently available by late 2026, though high-demand doses may still have occasional gaps.
For the most current shortage status, check the FDA Drug Shortages database regularly.
Questions for Your Doctor
- What are my options if I can't find my medication?
- Are there alternatives available?
- What happens if I have to stop my medication?
- How long might shortages last?
The Bottom Line
Shortages are easing but not gone. Wegovy 2.4 mg is now more available. Some Ozempic and Mounjaro doses still face gaps. Stay in touch with your pharmacy and doctor. Check the FDA shortage database regularly. Explore all your options, including compounded GLP-1 from verified sources when brand-name medication is unavailable.
This article is for information only and is not medical advice.
